A Combined Metabolomic and Proteomic Analysis of Gestational Diabetes Mellitus

The aim of this pilot study was to apply a novel combined metabolomic and proteomic approach in analysis of gestational diabetes mellitus. The investigation was performed with plasma samples derived from pregnant women with diagnosed gestational diabetes mellitus (n = 18) and a matched control group (n = 13). The mass spectrometry-based analyses allowed to determine 42 free amino acids and low molecular-weight peptide profiles. Different expressions of several peptides and altered amino acid profiles were observed in the analyzed groups. The combination of proteomic and metabolomic data allowed obtaining the model with a high discriminatory power, where amino acids ethanolamine, l-citrulline, l-asparagine, and peptide ions with m/z 1488.59; 4111.89 and 2913.15 had the highest contribution to the model. The sensitivity (94.44%) and specificity (84.62%), as well as the total group membership classification value (90.32%) calculated from the post hoc classification matrix of a joint model were the highest when compared with a single analysis of either amino acid levels or peptide ion intensities. The obtained results indicated a high potential of integration of proteomic and metabolomics analysis regardless the sample size. This promising approach together with clinical evaluation of the subjects can also be used in the study of other diseases.

[1]  W. Rayburn.  Diagnosis and classification of diabetes mellitus: highlights from the American Diabetes Association. , 1997, The Journal of reproductive medicine.

[2]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Network Boston.

[3]  D. Cucinotta,et al.  Preliminary report: Amino acid profile in platelets of diabetic patients. , 2001, Metabolism: clinical and experimental.

[4]  G. Pardi,et al.  Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus. , 2005, American journal of obstetrics and gynecology.

[5]  K. Nicolaides,et al.  First Trimester Sex Hormone-Binding Globulin and Subsequent Development of Preeclampsia or Other Adverse Pregnancy Outcomes , 2005, Hypertension in pregnancy.

[6]  M. Wolf,et al.  First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus. , 2003, American journal of obstetrics and gynecology.

[7]  F. Endo,et al.  Time-dependent changes in the plasma amino acid concentration in diabetes mellitus. , 2011, Molecular genetics and metabolism.

[8]  N. Beischer,et al.  Identification and Treatment of Women with Hyperglycaemia Diagnosed During Pregnancy Can Significantly Reduce Perinatal Mortality Rates * , 1996, The Australian & New Zealand journal of obstetrics & gynaecology.

[9]  F. Tinahones,et al.  Proteomic analysis of visceral adipose tissue in pre-obese patients with type 2 diabetes , 2013, Molecular and Cellular Endocrinology.

[10]  K. Czajkowski,et al.  [Polish Gynecological Society standards of medical care in management of women with diabetes]. , 2011, Ginekologia polska.

[11]  E. Reece,et al.  Factors associated with fetal macrosomia in offspring of gestational diabetic women. , 2000, The Journal of maternal-fetal medicine.

[12]  Jun Ye,et al.  First-Trimester Follistatin-Like-3 Levels in Pregnancies Complicated by Subsequent Gestational Diabetes Mellitus , 2009, Diabetes Care.

[13]  Surabhi Nanda,et al.  Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks , 2011, Prenatal diagnosis.

[14]  G. Roglić,et al.  Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. , 2014, Diabetes research and clinical practice.

[15]  George Lee,et al.  Evaluating feature selection strategies for high dimensional, small sample size datasets , 2011, 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[16]  Michael W. Varner,et al.  A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes , 2010 .

[17]  Z. Kokot,et al.  Effects of a Honeybee Sting on the Serum Free Amino Acid Profile in Humans , 2014, PloS one.

[18]  O. Langer,et al.  Gestational diabetes: the consequences of not treating. , 2005, American journal of obstetrics and gynecology.

[19]  E. Kandaraki,et al.  Relationship between neonatal birth weight and maternal plasma amino acid profiles in lean and obese nondiabetic women and in type I diabetic pregnant women. , 1988, Metabolism: clinical and experimental.

[20]  G. Rice,et al.  Screening for biomarkers predictive of gestational diabetes mellitus , 2008, Acta Diabetologica.

[21]  Z. Kokot,et al.  The application of fuzzy statistics and linear discriminant analysis as criteria for optimizing the preparation of plasma for matrix-assisted laser desorption/ionization mass spectrometry peptide profiling. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[22]  L. Marroqui,et al.  Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes , 2014, Nutrition Research Reviews.

[23]  Sebastian Gibb,et al.  MALDIquant: a versatile R package for the analysis of mass spectrometry data , 2012, Bioinform..

[24]  R. Ness,et al.  First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy , 2008, Clinical endocrinology.

[25]  E. Norwitz,et al.  Identification of Proteomic Biomarkers in Maternal Plasma in the Early Second Trimester That Predict the Subsequent Development of Gestational Diabetes , 2012, Reproductive Sciences.

[26]  Jianguo Xia,et al.  Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst , 2011, Nature Protocols.

[27]  N. Beischer,et al.  Identification and Treatment of Women With Hyperglycaemia Diagnosed During Pregnancy Can Significantly Reduce Perinatal Mortality Rates , 1997 .

[28]  N. Butte,et al.  Protein metabolism in insulin-treated gestational diabetes. , 1999, Diabetes care.

[29]  B. Liu,et al.  Altered Protein Expression in Gestational Diabetes Mellitus Placentas Provides Insight into Insulin Resistance and Coagulation/Fibrinolysis Pathways , 2012, PloS one.

[30]  David S. Wishart,et al.  MetaboAnalyst 2.0—a comprehensive server for metabolomic data analysis , 2012, Nucleic Acids Res..

[31]  M. Permezel,et al.  Gestational Diabetes Mellitus: Clinical Predictors and Long-Term Risk of Developing Type 2 Diabetes , 2007, Diabetes Care.

[32]  P. Newsholme,et al.  Nutrient regulation of insulin secretion and action. , 2014, The Journal of endocrinology.

[33]  Nele Friedrich,et al.  Metabolomics in diabetes research. , 2012, The Journal of endocrinology.

[34]  K. Leveno,et al.  Maternal Diabetes Mellitus and Infant Malformations , 2002, Obstetrics and gynecology.